-
-
-
-
-
-
-
Keros Therapeutics (KROS) Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) Reports FDA to Have AdCom for Donanemab
-
-
-
-
-
-
-
Vivani (VANI) Climbs 160% Following Positive NPM-115 Preclinical Weight Loss Data and Discloses NPM-139
-
-
-
-
-
-
-
IceCure Medical (ICCM) Says Study Using ProSense Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
-
-
-
-
-
-
-
Rocket Pharmaceuticals (RCKT) Announces Update on FDA Review Timeline of KRESLADI for Treatment of Severe Leukocyte Adhesion Deficiency-I
-
-
-
-
-
-
-
Ainos (AIMD) Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms
-
-
-
-
-
-
-
Kura Oncology (KURA) Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
-
5,475 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Hot FDA News reports.